ARCT vs WAT · rev $5.0M vs P/E 32, rev $3.17B
Arcturus Therapeutics Holdings Inc (ARCT) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported ARCT revenue for 2026-06-30 was $5.0M. Net income was -$50.7M. ARCT currently screens at market cap $369.4M.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
ARCT currently screens at market cap $369.4M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the ARCT and WAT stock pages for the full models.
Not investment advice.